Merck
MRK
#62
Rank
C$344.10 B
Marketcap
C$137.76
Share price
-1.16%
Change (1 day)
-2.57%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): C$10.67

According to Merck's latest financial reports the company's current EPS (TTM) is C$10.49. In 2024 the company made an earnings per share (EPS) of C$9.34 an increase over its 2023 EPS that were of C$0.21.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$10.6714.31%
2024C$9.344308.46%
2023C$0.21-97.32%
2022C$7.9210.92%
2021C$7.1484.68%
2020C$3.86-27.2%
2019C$5.3163.44%
2018C$3.25151.11%
2017C$1.29-54.58%
2016C$2.8530.21%
2015C$2.19-61.99%
2014C$5.75180.51%
2013C$2.05-31.82%
2012C$3.016.62%
2011C$2.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$2.38-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$14.42 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$28.35 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.10-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$5.12-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
C$4.97-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$0.87-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
C$10.17-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
C$11.13 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$18.00 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA